Ulrich Roelcke
Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and older.
Stadler C, Gramatzki D, Le Rhun E, Hottinger A, Hundsberger T, Roelcke U, Läubli H, Hofer S, Seystahl K, Wirsching H, Weller M, Roth P. Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and older. Neurooncol Pract 2023; 11:132-141.
20.10.2023Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and older.
20.10.2023Neurooncol Pract 2023; 11:132-141
Stadler Christina, Gramatzki Dorothee, Le Rhun Emilie, Hottinger Andreas Felix, Hundsberger Thomas, Roelcke Ulrich, Läubli Heinz, Hofer Silvia, Seystahl Katharina, Wirsching Hans-Georg, Weller Michael, Roth Patrick
Symptom Burden in Glioblastoma: A Prospective Pilot Study from Diagnosis to First Progression.
Roelcke U, Schwyzer L, Zeitlberger A, Hundsberger T. Symptom Burden in Glioblastoma: A Prospective Pilot Study from Diagnosis to First Progression. Oncology 2022; 101:145-152.
01.07.2022Symptom Burden in Glioblastoma: A Prospective Pilot Study from Diagnosis to First Progression.
01.07.2022Oncology 2022; 101:145-152
Roelcke Ulrich, Schwyzer Lucia, Zeitlberger Anna Maria, Hundsberger Thomas
Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM)
Hofer S, Baumert B, Läubli H, Gramatzki D, Reinert M, Pesce G, Schucht P, Frank I, Lehnick D, Weiss T, Wirsching H, Wolpert F, Roth P, Eggenberger N, Pflugshaupt T, Keller K, Imbach L, Roelcke U, Hutter G, Hundsberger T, Hertler C, Le Rhun E, Vasella F, Cordier D, Neidert M, Hottinger A, Migliorini D, Weller M. Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM). Swiss Med Wkly 2021; 151:w20501.
16.05.2021Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM)
16.05.2021Swiss Med Wkly 2021; 151:w20501
Hofer Silvia, Baumert Brigitta, Läubli Heinz, Gramatzki Dorothee, Reinert Michael, Pesce Gianfranco, Schucht Philippe, Frank Irène, Lehnick Dirk, Weiss Tobias, Wirsching Hans-Georg, Wolpert Fabian, Roth Patrick, Eggenberger Noemi, Pflugshaupt Tobias, Keller Kristina, Imbach Lukas, Roelcke Ulrich, Hutter Gregor, Hundsberger Thomas, Hertler Caroline, Le Rhun Emilie, Vasella Flavio, Cordier Dominik, Neidert Marian Christoph, Hottinger Andreas, Migliorini Denis, Weller Michael
MRI and FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial
Wirsching H, Tabatabai G, Ochsenbein A, Roth P, Remonda L, Conen K, Caparrotti F, von Moos R, Hottinger A, Hundsberger T, Weller J, Roelcke U, Weller M. MRI and FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial. Clin Cancer Res 2020; 27:179-188.
23.09.2020MRI and FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial
23.09.2020Clin Cancer Res 2020; 27:179-188
Wirsching Hans-Georg, Tabatabai Ghazaleh, Ochsenbein Adrian, Roth Patrick, Remonda Luca, Conen Katrin, Caparrotti Francesca, von Moos Roger, Hottinger Andreas F, Hundsberger Thomas, Weller Jonathan, Roelcke Ulrich, Weller Michael
A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults
Roth P, Hofer S, Pesce G, Roelcke U, Mamot C, Reinert M, Schucht P, Läubli H, Hundsberger T, Hottinger A, Weller M. A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults. Swiss Med Wkly 2020; 150:w20256.
18.06.2020A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults
18.06.2020Swiss Med Wkly 2020; 150:w20256
Roth Patrick, Hofer Silvia, Pesce Gianfranco, Roelcke Ulrich, Mamot Christoph, Reinert Michael, Schucht Philippe, Läubli Heinz, Hundsberger Thomas, Hottinger Andreas F, Weller Michael
Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study
Panje C, Putora P, Hundsberger T, Hottinger A, Roelcke U, Pesce G, Herrmann E, Matter-Walstra K. Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study. Swiss Med Wkly 2019; 149:w20153.
02.12.2019Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study
02.12.2019Swiss Med Wkly 2019; 149:w20153
Panje Cédric, Putora Paul Martin, Hundsberger Thomas, Hottinger Andreas F, Roelcke Ulrich, Pesce Gianfranco, Herrmann Evelyn, Matter-Walstra Klazien
[Meningioma: management of the most common brain tumour]
Hundsberger T, Surbeck W, Hader C, Putora P, Conen K, Roelcke U. [Meningioma: management of the most common brain tumour]. Praxis (Bern 1994) 2016; 105:445-51.
13.04.2016[Meningioma: management of the most common brain tumour]
13.04.2016Praxis (Bern 1994) 2016; 105:445-51
Hundsberger Thomas, Surbeck Werner, Hader Claudia, Putora Paul Martin, Conen Katrin, Roelcke Ulrich
[Neurological complications in cancer patients]
Hundsberger T, Roth P, Roelcke U. [Neurological complications in cancer patients]. Praxis (Bern 1994) 2014; 103:1009-16.
20.08.2014[Neurological complications in cancer patients]
20.08.2014Praxis (Bern 1994) 2014; 103:1009-16
Hundsberger Thomas, Roth Patrick, Roelcke Ulrich
Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patients
Hundsberger T, Tonder M, Hottinger A, Brügge D, Roelcke U, Putora P, Stupp R, Weller M. Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patients. J Neurooncol 2014; 118:321-328.
16.04.2014Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patients
16.04.2014J Neurooncol 2014; 118:321-328
Hundsberger Thomas, Tonder Michaela, Hottinger Andreas, Brügge Detlef, Roelcke Ulrich, Putora Paul Martin, Stupp Roger, Weller Michael
F-18 choline PET does not detect increased metabolism in F-18 fluoroethyltyrosine-negative low-grade gliomas
Roelcke U, Bruehlmeier M, Hefti M, Hundsberger T, Nitzsche E. F-18 choline PET does not detect increased metabolism in F-18 fluoroethyltyrosine-negative low-grade gliomas. Clin Nucl Med 2012; 37:e1-3.
26.01.2012F-18 choline PET does not detect increased metabolism in F-18 fluoroethyltyrosine-negative low-grade gliomas
26.01.2012Clin Nucl Med 2012; 37:e1-3
Roelcke Ulrich, Bruehlmeier Matthias, Hefti Martin, Hundsberger Thomas, Nitzsche Egbert U
Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials
Hofer S, Wick W, Zander T, Weder P, Roelcke U, Pichler J, Ochsenbein A, Marosi C, Lemke D, Huber U, Hottinger A, Greil R, Elandt K, Weller M. Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials. Acta Oncol 2011; 50:630-5.
18.04.2011Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials
18.04.2011Acta Oncol 2011; 50:630-5
Hofer Silvia, Wick Wolfgang, Zander Thilo, Weder Patrik, Roelcke Ulrich, Pichler Josef, Ochsenbein Adrian, Marosi Christine, Lemke Dieter, Huber Urs, Hottinger Andreas F, Greil Richard, Elandt Katarzyna, Weller Michael